Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 15:11:267.
doi: 10.3389/fendo.2020.00267. eCollection 2020.

The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging

Affiliations
Review

The Immune Landscape of Visceral Adipose Tissue During Obesity and Aging

Saad Khan et al. Front Endocrinol (Lausanne). .

Abstract

Obesity and aging represent major health burdens to the global adult population. Both conditions promote the development of associated metabolic diseases such as insulin resistance. The visceral adipose tissue (VAT) is a site that becomes dysfunctional during obesity and aging, and plays a significant role during their pathophysiology. The changes in obese and aging VAT are now recognized to be partly driven by a chronic local inflammatory state, characterized by immune cells that typically adopt an inflammatory phenotype during metabolic disease. Here, we summarize the current knowledge on the immune cell landscape of the VAT during lean, obese, and aged conditions, highlighting their similarities and differences. We also briefly discuss possible linked mechanisms that fuel obesity- and age-associated VAT dysfunction.

Keywords: aging; diabetes; immunology; immunometabolism; insulin resistance; metabolism; obesity; visceral adipose tissue.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Alterations in the visceral adipose tissue (VAT) immune cells during obesity and aging. In lean VAT, homeostasis is maintained via the secretion of anti-inflammatory cytokines by regulatory T cells (Tregs), T helper 2 (Th2) cells, tolerogenic macrophages, group 1 innate lymphoid cells (ILC1s), ILC2s, regulatory B cells (Bregs), B1 cells, and eosinophils. (Top) Obesity induces an expansion in adipocyte size and promotes a shift in the phenotype of local immune cells toward a pro-inflammatory state with increases in pro-inflammatory macrophages, NK Cells, B2 cells, Th1 CD4 cells, CD8+ T cells, and neutrophils. Inflammation of adipose tissue leads to tissue damage, cell death, and metabolic disturbances. (Bottom) During aging, the VAT is characterized by alterations in the immune cell environment. Emerging evidence indicates that these changes are associated with a shift in the phenotype of macrophages, expansion of B2 cells, age-associated B cells (AABs), CD8+ T cells and, paradoxically, regulatory T cells (Tregs). Changes in the composition of adipose tissue immune cells during aging may contribute to insulin resistance and ectopic lipid storage. Illustration created in the Mind the Graph platform: www.mindthegraph.com.

References

    1. Stevens GA, Singh GM, Lu Y, Danaei G, Lin JK, Finucane MM, et al. . National, regional, and global trends in adult overweight and obesity prevalences. Popul Health Metr. (2012) 10:22. 10.1186/1478-7954-10-22 - DOI - PMC - PubMed
    1. Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. (2008) 32:1431–7. 10.1038/ijo.2008.102 - DOI - PubMed
    1. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics. (2015) 33:673–89. 10.1007/s40273-014-0243-x - DOI - PMC - PubMed
    1. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. . The metabolic syndrome. Endocr Rev. (2008) 29:777–822. 10.1210/er.2008-0024 - DOI - PMC - PubMed
    1. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. (2014) 105:141–50. 10.1016/j.diabres.2014.04.006 - DOI - PubMed

Publication types